- Home
- FSEA vs ARTV Comparison
FSEA vs ARTV Comparison
Compare FSEA & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ARTV
- Stock Information
- Founded
- FSEA 1890
- ARTV 2019
- Country
- FSEA United States
- ARTV United States
- Employees
- FSEA N/A
- ARTV N/A
- Industry
- FSEA Savings Institutions
- ARTV
- Sector
- FSEA Finance
- ARTV
- Exchange
- FSEA Nasdaq
- ARTV NYSE
- Market Cap
- FSEA 53.3M
- ARTV 50.7M
- IPO Year
- FSEA N/A
- ARTV 2024
- Fundamental
- Price
- FSEA $11.31
- ARTV $1.63
- Analyst Decision
- FSEA
- ARTV Strong Buy
- Analyst Count
- FSEA 0
- ARTV 8
- Target Price
- FSEA N/A
- ARTV $18.14
- AVG Volume (30 Days)
- FSEA 5.9K
- ARTV 142.7K
- Earning Date
- FSEA 08-08-2025
- ARTV 05-08-2025
- Dividend Yield
- FSEA N/A
- ARTV N/A
- EPS Growth
- FSEA N/A
- ARTV N/A
- EPS
- FSEA 0.00
- ARTV N/A
- Revenue
- FSEA $16,196,000.00
- ARTV N/A
- Revenue This Year
- FSEA N/A
- ARTV N/A
- Revenue Next Year
- FSEA N/A
- ARTV N/A
- P/E Ratio
- FSEA $1,365.55
- ARTV N/A
- Revenue Growth
- FSEA 97.61
- ARTV N/A
- 52 Week Low
- FSEA $8.60
- ARTV $1.55
- 52 Week High
- FSEA $11.80
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- FSEA 51.70
- ARTV N/A
- Support Level
- FSEA $11.00
- ARTV N/A
- Resistance Level
- FSEA $11.33
- ARTV N/A
- Average True Range (ATR)
- FSEA 0.17
- ARTV 0.00
- MACD
- FSEA -0.01
- ARTV 0.00
- Stochastic Oscillator
- FSEA 60.00
- ARTV 0.00
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).